hemangioma
Information
- Disease name
- hemangioma
- Disease ID
- DOID:255
- Description
- "A cardiovascular organ benign neoplasm that has_material_basis_in endothelial cells that line blood vessels and is characterized by increased number of normal or abnormal vessels filled with blood." [url:http\://en.wikipedia.org/wiki/Hemangioma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00001417 | Completed | Direct Injection of Alcohol for the Treatment of Spinal Tumors | June 1994 | May 2002 | |
| NCT00004436 | Completed | N/A | Randomized Study of Hormonal Regulation of Infantile Hemangioma | July 1993 | June 2000 |
| NCT00374335 | Completed | N/A | Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas | September 2006 | December 2009 |
| NCT00394888 | Completed | N/A | Hemangioma Associated With High Rates of Morbidity | November 2005 | January 2010 |
| NCT00433940 | Completed | Immune Suppression Of Infants Treated With Steroids | October 2006 | July 2010 | |
| NCT01598116 | Completed | A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas | December 12, 2010 | January 10, 2017 | |
| NCT01685398 | Completed | Phase 3 | Topical Timolol for Superficial Infantile Hemangioma | September 2012 | March 2023 |
| NCT01908972 | Completed | Phase 4 | The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma | June 2013 | May 2015 |
| NCT02145884 | Completed | Phase 2 | Topical Timolol Gel for the Treatment of Infantile Hemangiomas | May 2014 | November 2016 |
| NCT02334930 | Completed | Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors | April 2015 | January 2016 | |
| NCT02342275 | Completed | Phase 3 | Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma | October 2013 | September 2018 |
| NCT02731287 | Completed | Phase 2 | Topical Timolol for Infantile Hemangioma in Early Proliferative Phase | March 2014 | March 2017 |
| NCT04065217 | Completed | N/A | The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial | October 14, 2018 | August 15, 2019 |
| NCT04077515 | Completed | Phase 4 | Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma | May 1, 2019 | December 31, 2022 |
| NCT04836884 | Completed | N/A | Vascular Anomaly Pathology and Genomics Biopsy Study | April 6, 2021 | January 31, 2022 |
| NCT05327309 | Completed | N/A | Role of Propranolol as Compared to Bleomycin in Management of Hemangioma | May 8, 2015 | January 1, 2018 |
| NCT00540566 | Completed | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | June 1999 | July 2008 | |
| NCT01072045 | Completed | Phase 2 | Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma | January 2010 | December 2014 |
| NCT01211080 | Completed | Off Label Use of Propranolol for Infancy Hemangiomas | August 2008 | October 2013 | |
| NCT01873131 | Recruiting | N/A | A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn | February 2011 | December 2028 |
| NCT03331744 | Recruiting | Clinical Characteristics of Infantile Hemangioma | October 6, 2017 | December 1, 2025 | |
| NCT01743885 | Terminated | Phase 3 | Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma | November 2012 | June 2015 |
| NCT00555464 | Terminated | Phase 2 | Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas | November 2007 | December 2012 |
| NCT01074437 | Terminated | Phase 2 | Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH) | February 2010 | February 2013 |
| NCT01147601 | Terminated | Early Phase 1 | Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas | March 2010 | August 2014 |
| NCT04020419 | Terminated | Early Phase 1 | Natural Berry Extract Treatment of Hemangiomas | December 1, 2020 | May 24, 2023 |
| NCT02496013 | Unknown status | Phase 1 | Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB | January 2014 | December 2017 |
| NCT02351245 | Unknown status | Clinical Characteristics of Lip Hemangiomas | December 2014 | ||
| NCT00490607 | Unknown status | A Prospective Study Comparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies Versus Pregnancies Complicated by Placental Abnormalities | |||
| NCT00974129 | Withdrawn | A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas | September 2009 | June 2012 |
- Disase is a (Disease Ontology)
- DOID:0060091
- Cross Reference ID (Disease Ontology)
- ICD10CM:D18.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:228.00
- Cross Reference ID (Disease Ontology)
- ICDO:9120/0
- Cross Reference ID (Disease Ontology)
- MESH:D006391
- Cross Reference ID (Disease Ontology)
- NCI:C3085
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154625006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0018916
- HPO alt_id (Human Phenotype Ontology)
- HP:0007444
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001028
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006391